Skip to content

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05759299
Acronym
STARGATE
Enrollment
10500
Registered
2023-03-08
Start date
2024-01-15
Completion date
2025-05-31
Last updated
2025-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Complication of Anesthesia

Keywords

airway management, anesthesia

Brief summary

According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anaesthesiology. Data from large perspective studies on current incidence of major peri-intubation adverse events are lacking in the anaesthesia setting, especially on outcomes such as peri-intubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increase the risks. Moreover, it has been documented that even transient hypotension during general anaesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major adverse events during advanced airway management for anaesthesia in patients undergoing elective or emergency surgery and in the setting of nonoperating room anesthesia. The secondary aim is to assess the current practice of airway management during anesthesia worldwide. STARGATE Study will be a large international observational study recruiting all consecutive adult (≥ 18 years old) patients undergoing general anesthesia in operating room and outside operating room. Primary outcome will be a composite of cardiovascular collapse, cardiac arrest and severe hypoxemia.

Detailed description

According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anesthesiology. Data from large perspective studies on current incidence of major peri-intubation adverse events are lacking in the anesthesia setting, especially on outcomes such as peri-intubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increase the risks. Moreover, it has been documented that even transient hypotension during general anesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major adverse events during advanced airway management for anesthesia in patients undergoing elective or emergency surgery and in the setting of non-operating room anesthesia. The secondary aim is to assess the current practice of airway management during anesthesia worldwide. Study design: International, multicenter, prospective cohort study Inclusion criteria: We will include all adult (≥ 18 years old) patients undergoing advanced airway management for general anaesthesia in operating room (OR) or non-operating room anaesthesia (NORA). Exclusion criteria: Airway management during cardiopulmonary resuscitation; critically ill patients undergoing intubation due to their underlying clinical condition. Primary outcome: At least one of the following major peri-intubation adverse events occurring within 30 minutes from induction or up to surgical incision: severe hypoxia, cardiovascular collapse, cardiac arrest. Study duration: All centers will enroll all consecutive patients meeting study criteria up to 50 maximum patients for each center. Collected data: We will collect the following information: * Informed consent and admission data * Demographic and clinical characteristics * Type of procedure (time, setting, type of surgery, elective or emergency * Airway evaluation (anticipated difficult airway management) * Monitoring applied during the procedure * Patient's parameters * Preoxygenation method and use of apnoeic oxygenation (position during preoxygenation, rapid sequence induction applied) * Drugs used for induction (molecules and doses) * Elective method for laryngoscopy * Operator's characteristics * Method used for the second (and following) attempt * Method used for adequate tube placement confirmation * Duration of laryngoscopy * Outcome of endotracheal intubation (total number of attempts, laryngoscopy view, minimum SpO2 during laryngoscopy, need for LMA) * Intubation-related complications (severe cardiovascular collapse, severe and mild hypoxemia, cardiac arrest, airway injury or any bleeding, aspiration of gastric contents, dental injury, emergency front of neck airway (FONA), cannot intubate cannot oxygenate scenario (CICO), unplanned need for ICU secondary to airway management complications) * Extubation procedure.

Interventions

PROCEDUREAdvanced airway management

Advanced airway management with either tracheal intubation or supraglottic airways performed after induction with hypnotic and/or opioid drugs

Sponsors

University of Turin, Italy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult (≥ 18 years old) patients undergoing advanced airway management for general anaesthesia in operating room (OR) or non-operating room anaesthesia (NORA).

Exclusion criteria

* Airway management during cardiopulmonary resuscitation. * Critically ill patients undergoing intubation due to their underlying clinical condition

Design outcomes

Primary

MeasureTime frameDescription
Major peri-intubation adverse event30 minutes from inductionDefined as at least one of the following events: * Cardiovascular collapse (at least one of the following): 1. Systolic arterial pressure \< 65 mmHg 2. Systolic arterial pressure \< 90 mmHg for \> 15 minutes 3. New need of vasopressors and/or fluid load \> 15 ml/kg to maintain the target blood pressure * Cardiac arrest * Severe hypoxemia (SpO2 \< 80%)

Secondary

MeasureTime frameDescription
Minor peri-intubation adverse events30 minutes from inductionAt least one of the following: * Moderate hypoxia (SpO2 \< 93%) * Airway injury * Clinically relevant bleeding * Oral aspiration of gastric contents * Dental injury
Difficult facemask ventilation30 minutes from inductionImpossibility to provide adequate ventilation because of one or more of the following problems: inadequate mask seal, excessive gas leak, or excessive resistance to the ingress or egress of gas
First pass success rate30 minutes from inductionIncidence of successful intubation after a single attempt of laryngoscopy

Other

MeasureTime frameDescription
Emergency front of neck access (eFONA)30 minutes from inductionEmergency need for invasive access to the patient's neck to provide adequate oxygenation (e.g. cricothyroidotomy, percutaneous tracheostomy, surgical tracheostomy).
Cannot intubate cannot oxygenate (CICO)30 minutes from inductionImpossibility to achieve a successful tracheal intubation and adequate patient's oxygenation
Unplanned need for ICU secondary to airway management complications24 hours from inductionUnplanned admission to ICU after an airway-related complication or prolonged/difficult instrumentation
In-hospital mortality28 days from inductionDeath during the same hospital admission

Countries

France, India, Ireland, Italy, United States

Contacts

Primary ContactVincenzo Russotto, MD
vincenzo.russotto@unito.it+393297893044
Backup ContactFrancesca Collino, MD
francesca.collino@unito.it+393334320985

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026